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Attrition From an Internet-Based Psychological
Intervention for Erectile Dysfunction: Who is
Likely to Drop Out?
MARITA P. McCABE AND EMILY PRICE
School of Psychology, Deakin University, Victoria, Australia
The current study evaluated the dropout rate from an internet-
based treatment program for erectile dysfunction (ED), and
determined reasons for attrition from this program. Only 12 of 40
treatment groupmen and 19 of 20 control groupmen completed the
post-test measures. Reasons for the men being excluded or dropping
out of the study are discussed. These reasons included medical
conditions that contributed to their ED, the man’s partner not being
interested in participating in the program, a lack ofmotivation from
the man, or the time commitment being too demanding.
A range of medical and psychological treatments have been used to
treat ED. These treatment approaches have demonstrated various levels
of effectiveness, but an underlying problem in evaluating these treatment
programs is the level of attrition that occurs between commencement and
completion of the program. These rates of attrition are frequently not
reported in published studies. However, when they are reported they are
quite substantial. The current study was designed to examine reasons for
attrition from an internet-based cognitive behavior therapy (CBT) program
to treat ED. It also examined differences in participants who completed the
program compared to those who dropped out on a range of variables.
Medical treatments for ED have been associated with high rates of
discontinuation. Vacuum constriction devices have been linked to high
patient attrition, which may result from the artificiality of the device
(Meinhardt, Lycklama a Nijeholt, Kropman, & Zwartendijk, 1993). High
attrition from intracavernous injection therapy is also common (Althof et al.,
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392 M. P. McCabe and E. Price
1991; Levine et al., 1989). Althof et al. reported a discontinuation rate of
57% following 2 years of intracavernous injection therapy. Factors identified
as contributing to attrition included refusal to self-inject, concern regarding
side effects, and dissatisfaction with treatment outcome (Althof et al., 1991).
In a follow-up investigation of men with ED who had initially responded
positively to injection therapy, Baniel et al. (2000) reported that 42.9% had
discontinued using this form of treatment over a 3-year period.
Low attrition has been reported in clinical trials of tadalafil (14%; Carrier
et al., 2005) and vardenafil (12%; Fisher et al., 2005). However, these
estimates of attrition were derived from patients who had been receiving
oral medication for only 12 weeks. Clinical trials conducted over a longer
follow-up period have revealed much higher rates of discontinuation from
PDE5 inhibitor therapy (Padma-Nathan, Eardley, Kloner, Laties, & Montorsi,
2002; Montorsi et al., 2004).
Attrition from PDE5 inhibitor therapy has also been found to be
significantly higher in clinical practice compared to clinical trials (Souverein,
Egberts, Meuleman, Urquhart, & Leufkens, 2002). In a multi-national sample
of men with ED recruited from the general population, 34% reported that
they had tried sildenafil, but only 16% were still using this medication
(Fisher et al., 2004). Other research findings have indicated that 41%–48%
of men with ED who receive a prescription for sildenafil do not return
for a second prescription (Jiann et al., 2003; McCullough, Barada, Fawzy,
Guay, & Hatzichristou, 2002). It is not surprising that discontinuation from
PDE5 inhibitor therapy is lower in clinical trials relative to clinical practice.
As suggested by Dean et al. (2006), clinical trials conducted to investigate
the effects of PDE5 inhibitors are generally associated with reimbursed
medication costs, as well as high quality patient support and education.
A much lower dropout rate was reported by Banner and Anderson (2007)
for a combined sildenafil and CBT treatment program, with the dropout rate
being on 3%.
Attrition is also high in psychological treatment programs for ED.
McCabe (2001) reported on the effectiveness of a CBT treatment program for
men with ED, and found that it was effective for 53.3% of men. However,
over half of the original participants dropped out of therapy. Similarly, Sarwer
and Durlak (1997) did not report dropouts specifically for men with ED, but
they did find that 55% of the entire sample of men and women who were
treated for sexual dysfunction did not return for the 3-month follow-up
assessment. Hawton, Catalan, and Fagg (1992) also adopted a CBT approach
to treat men with ED. This treatment was effective to some extent for over
two-thirds of the men with ED, but about a third of the original sample of
sexually dysfunctional participants failed to complete treatment.
Similar results have been found for internet-based treatment approaches.
Although data were not available for attrition from internet programs for



























Attrition and Psychological Therapy for ED 393
participants enrolled in a CBT internet-based program for panic disorder.
Andersson et al. (2005) obtained a dropout rate of 37% of their participants
who enrolled in a CBT internet program for social phobia.
The above findings demonstrate that a large proportion of men who
present for treatment of ED fail to complete the treatment program. However,
they do not systematically report on the reasons for dropout from therapy.
The current study was designed to examine the attrition from an internet-
based treatment program for ED, as well as assess the reasons why men
drop out of therapy.
METHOD
Participants
Eligibility criteria for participation in the internet-based program for ED
consisted of the following:
1) persistent or recurrent difficulties attaining or maintaining an erection
during sexual activity;
2) being aged 18 years or over;
3) absence of major medical or psychiatric problems;
4) involvement in a stable heterosexual relationship;
5) willingness and motivation from partners to participate in treatment;
6) regular internet access.
Men who were unable to meet the above criteria were excluded from
the study.
The recruitment process is illustrated in Figure 1. Participants were
prohibited from taking part in additional psychological treatment while
participating in the study. However, as it was expected that many participants
would already be using oral PDE5 inhibitors, medical treatment for ED
was permitted during the study. It was thought that cessation of medical
treatment upon commencing the study would have been likely to influence
responsiveness to psychological treatment. Men were instructed to maintain
a record of their usage of medical treatment for ED during the study.
Treatment
The treatment evaluated during this study was an internet-based CBT
program for men with ED and their partners. This program, named Rekindle,
focused on the resolution of psychological and relationship factors related
to ED. Rekindle consisted of three main treatment components, including
sensate focus, communication exercises, and e-mail contact with a therapist.



























394 M. P. McCabe and E. Price
Expressions of interest (n = 91) 
Included in study (n = 44) Not included in study (n = 47) 
Did not meet eligibility 
criteria
(n = 21) 
Reasons for exclusion: 
• Presence of major 
medical problem  
(n = 10) 
• Presence of major 
psychiatric disorder 
(n = 2) 
• No involvement in 
relationship (n = 1) 
• Partner not willing 
and motivated 
      (n = 1) 
• No regular internet 
access (n = 4) 
• Inability to meet time 




(n = 26) 
Randomly 
assigned to the 
treatment group  
(n = 24) + 16 
men from the 
control group 
Randomly 
assigned to the 
control group 
(n = 20) 
FIGURE 1. Recruitment and attrition process.
between different sections and pages of the program. Each webpage could
be easily printed so that participants could refer to the program when they
were not online. Rekindle was completed over the course of five modules,
with earlier modules providing a foundation for later modules. Men with
ED and their partners were encouraged to spend approximately 2 weeks
completing each of the modules. Therefore, Rekindle was designed as a
10-week program.
Procedure
Men were invited to participate in the study through online advertisements
posted at websites for Andrology Australia, Impotence Australia, and the
Sexual Dysfunction Association of the United Kingdom. All men were
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Expressions of interest to participate in the study were received from
44 men located in Australia and 47 men who were located overseas. Figure
1 outlines the reasons why 47 of these men did not continue in the study
group. Twenty six men did not proceed past obtaining information about
the study. A medical screen was either completed by the man’s GP (n =
21) or by the man himself (n = 44). Medical and psychiatric problems
that could exclude men from participating in the study included prostate
cancer, significant neurological damage, peripheral vascular disease, carotid
artery disease, heart disease, psychotic illness, major depressive disorder,
and substance abuse/dependency disorder (n = 12 men excluded for these
reasons). Risk factors that were also reported but did not result in exclusion
from the study included high blood pressure, high cholesterol, diabetes,
obesity, smoking, mild depression or dysthymia, and mild anxiety disorder.
In total, 65 men from both Australia and overseas provided informed
consent and completed the medical screen. Twelve men were referred back
to their general practitioner for medical treatment and were informed that
they were ineligible to participate in the study as they did not pass the
medical screen. A further nine men also did not proceed with the study due
to the reasons outlined in Figure 1. The remaining men who passed the
medical screen (n = 44) were included in the study, and randomly assigned
to either the treatment group (n = 24) or the control group (n = 20).
RESULTS
Among the participants who were randomly assigned to the treatment group
(n = 24), 17 (70.83%) dropped out of treatment and did not provide post-test
data. Among the participants who were randomly assigned to the control
group (n = 20), one did not provide post-test data. After completing the
waitlist phase of the study, 16 participants in the control group accepted
the offer to join the treatment group. Of these 16 participants, 11 (68.75%)
dropped out of treatment. Therefore, a total of 40 participants had entered
the treatment group over the course of the study, of which 28 had dropped
out, indicating an overall attrition rate of 70% from Rekindle.
Most attrition from Rekindle occurred during Module 1 (n = 19),
although participants also dropped out during Module 2 (n = 2), Module 3
(n = 5), and Module 5 (n = 2). Ten participants dropped out of treatment
without explanation. For participants who provided an explanation, attrition
occurred for the following reasons: separated from partner (n = 4); inability
to commit sufficient time (n = 8); did not believe program was suitable
(n = 3); partner unwilling to participate (n = 3).
Pretest data were compared between participants who completed
treatment and those who dropped out of treatment (see Table 1 for a
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TABLE 1. Pre-Test Comparison between Participants who Completed Treatment and







Continuous Variables Mean (SD) Mean (SD) t (38)
Age in years 54.50 (17.73) 52.43 (15.62) .37
Age of partner in years 51.58 (17.58) 47.43 (14.62) .78
Length of relationship in years 19.33 (21.30) 13.38 (17.27) .93
Duration of ED in years 5.19 (3.66) 6.68 (4.53) −1.00
Sexual function
Erectile function 14.42 (6.32) 12.29 (7.24) .89
Orgasmic function 5.83 (2.89) 5.96 (3.69) −.11
Sexual desire 6.25 (2.30) 6.07 (2.12) .24
Overall satisfaction 4.83 (2.13) 4.54 (2.29) .39
Relationships
Overall relationship satisfaction 16.83 (3.04) 16.46 (2.69) .38
Sexual relationship satisfaction 34.17 (11.44) 32.21 (15.48) .39
Sexual relationship satisfaction 37.76 (22.36) 36.50 (22.23) .17
Personal well-being
Physical health 78.27 (9.69) 77.51 (10.59) .21
Psychological health 67.01 (12.11) 68.01 (10.82) −.26
Social relationships 54.17 (12.05) 54.01 (17.91) .03
Environment 80.21 (15.15) 76.34 (11.61) .88
Self-esteem 55.73 (25.90) 48.21 (24.99) .86
Dichotomous variables n (%) n (%) χ 2(4)
Location .00
Australia 6 (50.00) 13 (46.43)
Overseas 6 (50.00) 15 (53.57)
Used PDE5 inhibitors 7 (58.33) 12 (42.86) .31
Used penile injection therapy 0 (0.00) 1 (3.57) .00
Frequency of ED .00
Less than 50% of the time 3 (25.00) 6 (21.43)
More than 50% of the time 9 (75.00) 22 (78.57)
Possessed one or more risk factors 5 (41.67) 15 (53.57) .12
Risk factors reported
High blood pressure 2 (16.67) 7 (25.00) .03
High cholesterol 2 (16.67) 7 (25.00) .03
Diabetes 0 (0.00) 3 (10.71) .28
Obesity 2 (16.67) 3 (10.71) .00
Smoking 1 (8.33) 3 (10.71) .00
Mild depression 2 (16.67) 4 (14.28) .00
Mild anxiety disorder 1 (8.33) 1 (3.57) .00
t-tests were used to compare continuous variables, and chi-square tests
for independence were used to compare dichotomous variables. Significant
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dropped out of treatment were not found on any of the variables. Therefore,
these variables were unable to explain attrition.
Of the 12 participants in the treatment group who completed Rekindle,
eight (66.67%) went on to complete the 3-month follow-up investigation.
For one participant, the study period ended before their 3-month follow-up
period had been reached. One participant was unable to provide follow-up
data due to illness. Two participants dropped out during the follow-up period
without explanation.
DISCUSSION
With 70% of men dropping out of Rekindle, attrition from the program
was high. A comparison of men who completed treatment and those who
discontinued treatment revealed no significant group differences at pretest in
relation to age, age of partner, length of relationship, duration of ED, usage
of medical treatment for ED, medical health, country of residence, frequency
of ED, sexual function, relationships, or personal well-being. Therefore, high
attrition from Rekindle was unable to be explained by these variables.
One variable that was not measured, but which may explain the large
proportion of men who discontinued treatment, was the level of motivation
of participants. An examination of the reasons provided by participants for
discontinuing Rekindle suggested that attrition was largely attributable to
limited motivation. For example, some participants felt that the program
was unsuitable for them, or that they did not have time to complete
the necessary sensate focus activities and communication exercises. Others
indicated that their partner was unwilling to participate. The fact that most
couples discontinued treatment during the first module also supported the
proposal that attrition from Rekindle was largely due to limited motivation.
Specifically, it was likely that many couples entered Rekindle without fully
comprehending the intensity of the program, subsequently discontinuing
when they recognized the level of commitment that was required.
Following the medicalization of ED, the perception that this disorder
can be alleviated with a “quick fix” has been widely promoted (Loe, 2001).
Given that some men expressed concern over not experiencing greater
improvements in erectile function after the first and second module, it is
possible that similarly rapid results had been expected from Rekindle. For
other couples, it was possible that they were superficially aware of the
intensity of the program upon commencing Rekindle. However, it was not
until they actively started to participate in the sensate focus sessions and
communication exercises that their limited motivation became apparent.
The dropout rate in the current study was higher than that reported
from medical interventions for ED. These interventions suggest that about
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However, none of these treatment programs have determined whether or
not men continue with treatment after the completion of the clinical trail. It
is possible that men on medical treatments also cease taking the medication
and that the attrition rate is high. In fact, other studies have demonstrated
that the dropout rate from the use of PDE5 inhibitors was high. (e.g., Fisher
et al., 2004; McCabe & Matic, 2007; Souverein et al., 2002).
Attrition from Rekindle was much higher than has been reported
for face-to-face psychological treatments for sexual dysfunction, where
discontinuation rates have been found to range from between 1.6% and
52.6% (Hawton et al., 1992; Kilmann et al., 1987; McCabe, 2001; Reynolds,
Cohen, Schochet, Price, & Anderson, 1981; Sarwer & Durlak, 1997). This
finding may be explained by the fact that during face-to-face therapy, the
therapist has an opportunity within the session to address factors that may
be inhibiting motivation to participate in treatment, such as ambivalence to
change, lack of confidence in the treatment, or limited enthusiasm.
The opportunity for the therapist to address factors affecting motivation
is more limited during internet-based treatment. Most of the problems
reported by men during e-mail contact were representative of difficulties in
maintaining motivation. For example, difficulties balancing priorities, having
unrealistic expectations of recovery, and difficulties remaining abstinent
from intercourse and ejaculation, were all suggestive of ambivalence about
treatment. However, certain factors inherent in e-mail contact made it difficult
for the therapist to address motivation among these men. As e-mail contact is
asynchronous, it was easy for participants to fall into the trap of delaying their
responses, and subsequently forgetting to reply to the therapist altogether.
The anonymity of e-mail contact also reduced any social pressure to respond
to the therapist, and made it easy for participants to drop out of treatment
without explanation or a need to rationalize their decision. Difficulties
improving motivation among individuals during internet-based sex therapy
were similarly identified by Hall (2004).
Treatment dropout was also much higher in this study than has been
reported in past investigations of internet-based psychological treatments.
Attrition from internet-based CBT for anxiety and depression has been
found to range from between 20% and 37.5% (Andersson et al., 2005, 2006;
Christensen, Griffiths, & Jorm, 2004; Richards & Alvarenga, 2002). Higher
attrition from Rekindle compared to other internet-based treatments may
reflect the intensity and content of the current program. That is, internet
treatments developed for anxiety and depression may not have involved
the same investment of time and energy as Rekindle. It is also possible that
higher attrition reflected the need for both the man and his partner to be
willing and motivated in order to complete Rekindle, whereas treatment of
anxiety and depression requires commitment from only one person. It is
possible that the man’s partner also experienced sexual problems, which
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difficult for men to confront and attempt to resolve their sexual problems,
as opposed to problems related to anxiety or depression.
It is likely that Rekindle is not satisfactory for resolving all cases of
ED. For those men who completed treatment, Rekindle was found to be
effective (McCabe, Price, Piterman, & Lording, 2007), which suggests that it
is useful for some men with ED. In cases where ED is more severe or has
been established for a significant period of time, a more intensive invention
than can be offered in the context of a 10-week internet-based CBT program
may be required. When other co-morbid sexual dysfunctions are present, or
when the level of discord with the general relationship is high, Rekindle may
also need to be supplemented with additional treatment.
It may be useful to formally assess motivation levels prior to commenc-
ing Rekindle. This would enable unmotivated couples to be excluded from
the program until they are ready to participate. However, it is often not until
couples actively commence Rekindle that low motivation becomes apparent.
As such, it may be more useful to develop effective strategies for improving
motivation while couples are completing the program. For example, given
that e-mail contact is a restrictive medium for motivating couples, where
possible, engagement in Rekindle may be enhanced by using face-to-
face contact or telephone contact with a therapist. Web-based discussion
groups may also increase motivation by enabling individuals to share their
experiences with other users of the program. Addressing the sexual problems
of the partner, should they become apparent during therapy, may also
improve the retention of the man and his partner in the therapy program.
It is also possible that a combination of psychological and medical
treatment for ED may be more effective than one treatment on its own. The
dropout from medical treatment is high, but this may be due to the lack
of focus on individual and interpersonal factors that may have caused or
maintained the problem. However, a medical intervention may be useful to
assist a man to achieve an erection, and so provide him with the confidence
to continue with the CBT intervention that can resolve his relationship
problems. Further research is needed to explore reasons for attrition from a
range of therapeutic intervention for ED. It will then be possible to develop
programs that address these problems, and are more appropriate for men
with ED and their partner.
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